California to end Walgreens contract after abortion dispute

By AP News

Share:

California Gov. Gavin Newsom is withdrawing a $54 million contract with Walgreens

Abortion Pill Pharmacies Explainer

SACRAMENTO, Calif. (AP) — California Gov. Gavin Newsom on Wednesday withdrew a $54 million contract with Walgreens after the pharmacy giant indicated it would not sell an abortion pill by mail in some conservative-led states.

Newsom on Wednesday ordered state officials to not renew a contract with Walgreens to purchase specialty pharmacy prescription drugs for California's prison health care system, including antivirual and antifungal drugs and medication used for congestive heart failure. Walgreens has gotten about $54 million from the contract, which expires April 30.

Newsom's office said the state will buy the drugs somewhere else.

“California will not stand by as corporations cave to extremists and cut off critical access to reproductive care and freedom,” Newsom said in a news release. “California is on track to be the fourth largest economy in the world and we will leverage our market power to defend the right to choose.”

A representative from Walgreens, based in the northern Chicago suburb of Deerfield, Ill., did not respond to an email from the Associated Press seeking comment. But earlier this week, the company said in a statement the company plans to dispense the drug, called mifepristone, "in any jurisdiction where it is legally permissible to do so.”

“Providing legally approved medications to patients is what pharmacies do, and is rooted in our commitment to the communities in which we operate,” according to a statement posted onto the company's website.

Mifepristone is a pill that when combined with another pill will end a pregnancy. The U.S. Food and Drug Administration approved the pill in 2000 for use in up to the 10th week of pregnancy. Today, more than half of all abortions in the U.S. are done by pills, according to the Guttmacher Institute, a research group that supports abortion rights.

After the U.S. Supreme Court last year overturned the federal right to an abortion, more than a dozen states have restricted the use of abortion pills. But those restrictions are being challenged in court.

Attorneys general in 20 states, mostly with Republican governors, have warned Walgreens and CVS they could face legal consequences if they sell abortion pills in their states. Last week, Walgreens confirmed it sent a response to each attorney general saying it would not dispense the drug in their states.

Newsom responded to that news on Monday, posting in a message on Twitter that California won't be doing business with Walgreens “or any company that cowers to the extremists and puts women's lives at risk.”

“We're done,” Newsom said.

Losing the California contract will have a small impact on Walgreens' revenues, as the company reported $132.7 billion in sales for the fiscal year that ended Aug. 31.

But for Newsom, the move is more about solidifying California's role as a leader in what he has called “reproductive freedom.”

Newsom has vowed to make California a sanctuary for people in other states where abortion is illegal or severely restricted. Last year, Newsom signed more than a dozen new laws aiming to protect abortion rights, including signing off on $20 million in new spending to help pay for the travel and lodging expenses for people to come to California from other states to get an abortion.

Share:

Author: AP News

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Originally published by Associated Press Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

Sign up for Investing Intel Newsletter